ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation
Authors:
Open Access
- 6 October 2021
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (10) , 1-12
Abstract
Sphingolipid metabolic dysregulation has increasingly been considered to be a drug-resistance mechanism for a variety of tumors. In this study, through an LC–MS assay, LIM and SH3 protein 1 (LASP1) was identified as a sphingolipid-metabolism-involved protein, and short-chain enoyl-CoA hydratase (ECHS1) was identified as a new LASP1-interacting protein through a protein assay in colorectal cancer (CRC). Gain- and loss-of-function analyses demonstrated the stimulatory role played by ECHS1 in CRC cell proliferation, migration, and invasion in vitro and in vivo. Mechanistic studies of the underlying tumor-supportive oncometabolism indicate that ECHS1 enables altering ceramide (Cer) metabolism that increases glycosphingolipid synthesis (HexCer) by promoting UDP-glucose ceramide glycosyltransferase (UGCG). Further analysis showed that ECHS1 promotes CRC progression and drug resistance by releasing reactive oxygen species (ROS) and interfering mitochondrial membrane potential via the PI3K/Akt/mTOR-dependent signaling pathway. Meanwhile, the phenomenon of promoting the survival and drug resistance of CRC cells caused by ECHS1 could be reversed by Eliglustat, a specific inhibitor of UCCG, in vitro and in vivo. IHC assay showed that ECHS1 was overexpressed in CRC tissues, which was related to the differentiation and poor prognosis of CRC patients. This study provides new insight into the mechanism by which phospholipids promote drug resistance in CRC and identifies potential targets for future therapies.Keywords
Funding Information
- China Postdoctoral Science Foundation (F119280111)
- National Natural Science Foundation of China (81902946, 81972813)
This publication has 37 references indexed in Scilit:
- miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathwayEuropean Journal of Cancer, 2013
- ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cellsCancer Letters, 2013
- Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cellsVirology Journal, 2012
- HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stressFree Radical Biology and Medicine, 2011
- Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometryNature Protocols, 2011
- Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1Gut, 2010
- Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisationBritish Journal of Cancer, 2007
- Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cellsExperimental Cell Research, 2006
- Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane PermeabilizationJournal of Experimental Medicine, 2004
- Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.Proceedings of the National Academy of Sciences, 1996